May 08 , 2015
The Canadian Clinical Trials Asset Map (CCTAM) will be launched on Thursday, June 4th, 2015.in Ottawa.
The CCTAM is a pan-Canadian, robust, online, searchable database designed to communicate Canada’s clinical research strengths to all stakeholders, including clinical trial sponsors. Its purpose is to:
- Better enable sponsors of clinical trials to identify clinical research sites and investigators, and facilitate the conduct of feasibility assessments.
- Become a comprehensive database for all Canadian clinical research assets; the essential tool for anyone planning to conduct clinical research in Canada.
- Position Canada as an attractive destination for the conduct of clinical trials in the global marketplace.
The CCTAM has been populated with data from other asset maps; however once launched, researchers will have an opportunity to register on CCTAM.